Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> ...

NanoVibronix (NAOV) announced that an independent health service study of its UroShield is published in The Australian and New Zealand ...

NanoVibronix (Nasdaq:NAOV) announced today that it intends to effect a reverse stock split of its common stock.

NanoVibronix Inc. (NAOV), a medical device company with a market capitalization of $1.73 million, saw its stock price touch a 52-week low of $0.44, reflecting a challenging period for the firm.

ELMSFORD, N.Y., February 14, 2025--NanoVibronix, Inc. (NASDAQ: NAOV) (the "Company"), a medical technology company specializing in non-invasive therapeutic devices, today announced the completion ...

NanoVibronix, Inc. Announces Acquisition of ENvue Medical Holdings, Corp. NanoVibronix, Inc. (NASDAQ: NAOV) (the “Company”), a medical technology company specializing in non-invasive ...

(RTTNews) - NanoVibronix, Inc. (NAOV), a US-based medical device company, Friday announced the acquisition of ENvue Medical Holdings Corp., a leader in enteral feeding solutions. The financial ...

NanoVibronix, Inc. (NASDAQ: NAOV) (the "Company"), a medical technology company specializing in non-invasive therapeutic devices, today announced that an independent health service study of its ...

On February 24, 2025, NanoVibronix, Inc., a Delaware-incorporated company specializing in orthopedic and surgical devices, received shareholder approval for a reverse stock split and other significant ...

NanoVibronix, Inc. engages in the development of noninvasive biological response-activating devices. The firm's products include UroShield and PainShield. It operates through the following ...